ZebraTox is revolutionizing pre-clinical drug testing with a novel, high throughput toxicity screening platform in zebrafish. Our patent-pending genotoxicity assay bridges the gap between the cost efficacy of in vitro, toxicity studies and the translatability of live vertebrate studies to help streamline the drug development pipeline. Our goal is to reduce the risk of late-stage failures and accelerate the path to potentially life-saving therapeutics by making toxicity screening faster and more affordable than existing methods.
Company Details
Zebratox Questions
Zebratox's LinkedIn profile is https://www.linkedin.com/company/zebratox
Zebratox has
2 employees.
View email and phone details for 2
employees at Zebratox.
Zebratox's industry is
Biotechnology Research
Zebratox's top competitors are
Aaham Western Region,
Animate Biosciences, Inc.,
Escend Consulting,
Nasaclip,
Persephoni Bio,
Arizona State Orthopaedics, Llc,
Altrixbio Inc.,
Vasowatch Inc,
Aloe Therapeutics,
Seed2table.
Zebratox's categories are Biotechnology Research
Zebratox's founding year is 2025
